KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Gross Margin (2017 - 2025)

Guardant Health (GH) has disclosed Gross Margin for 9 consecutive years, with 64.63% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 1654.0% to 64.63% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 57.11% through Dec 2025, up 333.0% year-over-year, with the annual reading at 64.46% for FY2025, 1384.0% up from the prior year.
  • Gross Margin hit 64.63% in Q4 2025 for Guardant Health, up from 51.97% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 222.36% in Q4 2021 to a low of 31.54% in Q3 2022.
  • Historically, Gross Margin has averaged 63.84% across 5 years, with a median of 50.14% in 2023.
  • Biggest five-year swings in Gross Margin: soared 16231bps in 2021 and later crashed -18653bps in 2022.
  • Year by year, Gross Margin stood at 222.36% in 2021, then tumbled by -84bps to 35.83% in 2022, then soared by 418bps to 185.58% in 2023, then crashed by -74bps to 48.09% in 2024, then surged by 34bps to 64.63% in 2025.
  • Business Quant data shows Gross Margin for GH at 64.63% in Q4 2025, 51.97% in Q3 2025, and 48.47% in Q2 2025.